Home / Resource Library / Ibrutinib Therapy in Patients with Waldenstrom Macroglobulinemia: Outcomes Outside of Clinical Trial Setting

Ibrutinib Therapy in Patients with Waldenstrom Macroglobulinemia: Outcomes Outside of Clinical Trial Setting

Study compared real world outcomes of Waldenstrom patients treated with Ibrutinib to clinical trials.